The acute phase parameters C-reactive protein (CRP) and serum amyloid A (SAA) increased in parallel with COVID-19 severity reaching significance in all patients with moderate and severe COVID-19 (Figures 1A, B). This evidence concerns the gene CRP and COVID-19.